← 產業報告目錄

Ultrasound AI Market by Product (AI-enabled System (POCUS, Handheld, Cart), Solutions (Image Evaluation, Radiology)), Brand (Echopac, Aplio, Acuson, Butterfly), Application (OB/GYN, Cardio, Ortho), End User (Hospital, Clinic, ACC) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-08-30頁數 278報告編號 HIT9486

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global Ultrasound AI market is projected to reach USD 6.88 billion by 2030 from USD 2.35 billion in 2025, growing at a CAGR of 24.0% during the forecast period. The growth of the market is driven by the increasing demand for accurate and early disease diagnosis, advancements in machine learning algorithms for image analysis, and the integration of AI to enhance workflow efficiency and reduce human error. The rising adoption of portable and point-of-care ultrasound devices, coupled with growing applications in cardiology, obstetrics/gynecology, oncology, and emergency care, is further expected to fuel market expansion. By product type, the AI-enabled solutions/software segment is expected to register the highest CAGR during the forecast period. By product type, the AI-enabled solutions/software segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to the cost-efficiency and flexible provision to enhance diagnostic accuracy and workflow efficiency without the requirement of primary hardware upgrades. AI software benefits from scalability and continuous innovation. Unlike hardware, which requires significant investment cycles, software can be easily updated with new algorithms, clinical applications, and regulatory-compliant features. The growing adoption of cloud-based platforms, telemedicine, and remote diagnostics also expands the role of AI software in healthcare ecosystems, fueling market growth. By brand, the EchoPAC segment accounted for the largest share of the market in 2024. By brand, the EchoPAC segment accounts for the highest market share in the ultrasound AI market by brand because it is GE Healthcare’s widely adopted advanced analysis software, specifically designed for cardiovascular ultrasound. It offers robust AI-driven tools for strain imaging, 3D/4D quantification, and automated measurements, which significantly improve diagnostic accuracy and workflow efficiency. Its seamless integration with GE’s large installed base of ultrasound systems, strong clinical validation, and broad use across leading hospitals and cardiology centers worldwide give EchoPAC a competitive edge, enabling it to dominate market share in the AI-enabled ultrasound segment. By end user, the hospitals & surgical centers segment accounted for the largest share of the market in 2024. In 20254, the hospitals & surgical centers segment accounted for the largest share of the market due to its high patient inflow, broad range of diagnostic and interventional procedures, and extensive adoption of advanced imaging technologies. These facilities leverage AI-enabled ultrasound systems for accurate, efficient, and real-time imaging across various specialties, including cardiology, obstetrics/gynecology, oncology, and emergency care. The strong financial capacity, skilled workforce, and integration of AI tools into routine workflows further enhance operational efficiency and patient outcomes, solidifying their dominant position over other end-user segments such as research institutes or smaller clinics. By region, the Asia Pacific is expected to register the highest growth rate in the market during the forecast period. The Asia Pacific region is expected to witness the highest growth rate in the Ultrasound AI market due to rapid advancements in healthcare infrastructure, increasing adoption of advanced imaging technologies, and rising investments in AI-driven medical solutions. Factors such as a large and aging population, growing prevalence of chronic and lifestyle-related diseases, and expanding access to healthcare services in countries like China, India, and Japan are driving demand. Additionally, government initiatives promoting digital health, increasing awareness of early disease detection, and the entry of global and local Ultrasound AI manufacturers are further accelerating market expansion in the region. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%) • By Designation: C-level Executives (55%), Directors (27%), and Others (18%) By Region: North America (35%), Europe (32%), Asia Pacific (25%), Latin America (6%), and the Middle East & Africa (2%) The prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), Hologic Inc. (US), Samsung Electronics Co., Ltd (South Korea), Butterfly Network (US), Chison Medical Technologies Co., Ltd (China), and Clarius (Canada), among others. Research Coverage The ultrasound AI market is segmented by product type, brand, application, end user, and region. Key factors influencing market growth include driving forces, restraints, opportunities, and challenges for stakeholders. The report also reviews the leading companies competing in the Ultrasound AI market. A micro-level analysis can be conducted to examine trends, growth opportunities, and contributions to the market. Additionally, it highlights potential revenue growth opportunities across various market segments in five major regions. Key Benefits of Buying the Report The report is valuable for new entrants in the Ultrasound AI market as it provides comprehensive information about the market. This information is essential for understanding various investment opportunities. The report offers insights into both key and smaller players in the market, which can help in creating a solid basis for risk analysis when making investment decisions. It accurately segments the market by end users and regions, providing focused insights into specific market segments. Additionally, the report highlights key trends, challenges, growth drivers, and opportunities to support strategic decision-making through a thorough analysis. The report provides insights into the following points: • Key drivers (rising prevalence of chronic diseases, integration with portable and point-of-care devices, advancements in AI algorithms, rising healthcare expenditure and supportive government policies, rising collaborations between med-tech companies and ai startups), restraints (high maintenance and upgrade costs, regulatory hurdles and approval delays), opportunities (expansion of portable ultrasound, integration with electronic health records), and challenges (resistance to adoption among clinicians, data privacy and security concerns) fueling the market growth of ultrasound ai market. • Product Development/Innovation: Emerging technologies in space, R&D, recent product & service launches in the Ultrasound AI market. • Market Growth: In-depth insights into remunerative markets report analyze the Ultrasound AI market across varied geographies. • Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the Ultrasound AI market • Competitive Assessment: Detailed assessment of market share, service offerings, leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), and FUJIFILM Corporation (Japan), among others.
目錄 Table of Contents
1 INTRODUCTION 24 1.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.3 MARKET SCOPE 25 1.3.1 ULTRASOUND AI MARKET SEGMENTATION 25 1.3.2 INCLUSIONS AND EXCLUSIONS 26 1.3.3 YEARS CONSIDERED 26 1.4 CURRENCY CONSIDERED 27 1.5 MARKET STAKEHOLDERS 27 2 RESEARCH METHODOLOGY 28 2.1 RESEARCH DATA 28 2.1.1 SECONDARY RESEARCH 29 2.1.1.1 Key data from secondary sources 30 2.1.2 PRIMARY RESEARCH 31 2.1.2.1 Key industry insights 32 2.2 MARKET SIZE ESTIMATION APPROACH 33 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 35 2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 36 2.3 MARKET FORECASTING APPROACH 38 2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 39 2.5 MARKET SHARE ASSESSMENT 40 2.6 RESEARCH ASSUMPTIONS 40 2.7 RESEARCH LIMITATIONS 40 2.8 RISK ASSESSMENT 41 3 EXECUTIVE SUMMARY 42 4 PREMIUM INSIGHTS 45 4.1 ULTRASOUND AI MARKET OVERVIEW 45 4.2 NORTH AMERICA: ULTRASOUND AI MARKET, BY COUNTRY AND END USER, 2025 46 4.3 GEOGRAPHIC SNAPSHOT OF ULTRASOUND AI MARKET 47 5 MARKET OVERVIEW 48 5.1 INTRODUCTION 48 5.2 MARKET DYNAMICS 48 5.2.1 DRIVERS 49 5.2.1.1 Integration with portable and point-of-care devices 49 5.2.1.2 Advancements in AI algorithms 50 5.2.1.3 Rising healthcare expenditure and supportive government policies 50 5.2.1.4 Rising collaboration between MedTech companies and AI startups 51 5.2.2 RESTRAINTS 52 5.2.2.1 High maintenance and upgrade costs 52 5.2.2.2 Regulatory hurdles and approval delays 52 5.2.3 OPPORTUNITIES 53 5.2.3.1 Expansion of portable ultrasound with AI integration 53 5.2.3.2 AI-driven fetal health monitoring 53 5.2.4 CHALLENGES 54 5.2.4.1 Resistance to adoption among clinicians 54 5.2.4.2 Data privacy and security concerns 54 5.3 VALUE CHAIN ANALYSIS 55 5.4 SUPPLY CHAIN ANALYSIS 56 5.4.1 PROMINENT COMPANIES 56 5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES 56 5.4.3 END USERS 56 5.5 PORTER’S FIVE FORCES ANALYSIS 57 5.5.1 THREAT OF NEW ENTRANTS 58 5.5.2 BARGAINING POWER OF SUPPLIERS 58 5.5.3 BARGAINING POWER OF BUYERS 58 5.5.4 THREAT OF SUBSTITUTES 59 5.5.5 INTENSITY OF COMPETITIVE RIVALRY 59 5.6 KEY STAKEHOLDERS & BUYING CRITERIA 59 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 59 5.6.2 BUYING CRITERIA 60 5.7 PATENT ANALYSIS 62 5.8 TRADE DATA ANALYSIS 64 5.8.1 IMPORT DATA 64 5.8.2 EXPORT DATA 65 5.9 KEY CONFERENCES & EVENTS, 2025–2026 66 5.10 UNMET NEEDS AND KEY PAIN POINTS 67 5.11 ECOSYSTEM ANALYSIS 67 5.12 IMPACT OF 2025 US TARIFF―ULTRASOUND AI MARKET 68 5.12.1 INTRODUCTION 68 5.12.2 KEY TARIFF RATES 69 5.12.3 PRICE IMPACT ANALYSIS 69 5.12.4 IMPACT ON COUNTRY/REGION 70 5.12.4.1 US 70 5.12.4.2 Europe 70 5.12.4.3 Asia Pacific 70 5.12.5 IMPACT ON END USERS 71 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 72 5.14 TECHNOLOGY ANALYSIS 72 5.14.1 KEY TECHNOLOGIES 73 5.14.1.1 3D/4D imaging with AI enhancement 73 5.14.1.2 Cloud computing & data analytics 73 5.14.2 COMPLEMENTARY TECHNOLOGIES 73 5.14.2.1 Wearable devices & IoMT 73 5.14.3 ADJACENT TECHNOLOGIES 73 5.14.3.1 Positron emission tomography (PET) and molecular imaging 73 5.15 CASE STUDY ANALYSIS 74 5.15.1 IMV OFFERS EFFICIENT POWER FOR HANDHELD ULTRASOUND UNITS 74 5.15.2 ADVANCEMENTS IN USE OF ULTRASOUND AI PRE-HOSPITAL EMERGENCIES AND DISASTER RESPONSE SETTINGS 74 5.15.3 USE OF HANDHELD ULTRASOUND AI IN RURAL HOSPITAL IN GUATEMALA 75 5.16 REGULATORY ANALYSIS 75 5.16.1 NORTH AMERICA 75 5.16.1.1 US 75 5.16.1.2 Canada 76 5.16.2 EUROPE 77 5.16.3 ASIA PACIFIC 77 5.16.3.1 Japan 77 5.16.3.2 China 78 5.16.3.3 India 79 5.16.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 5.17 INVESTMENT & FUNDING SCENARIO 82 5.18 PRICING ANALYSIS 84 5.18.1 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022–2024 (USD) 85 5.18.2 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, 2024 (USD) 86 5.19 REIMBURSEMENT SCENARIO 87 6 ULTRASOUND AI MARKET, BY PRODUCT TYPE 88 6.1 INTRODUCTION 89 6.2 AI-ENABLED ULTRASOUND SYSTEMS 89 6.2.1 HANDHELD ULTRASOUND 90 6.2.1.1 Rapid diagnostic capabilities to drive market 90 6.2.2 CART-BASED ULTRASOUND 91 6.2.2.1 Enhanced clinical imaging to fuel growth 91 6.2.3 POINT OF CARE ULTRASOUND 93 6.2.3.1 Support for diverse clinical applications to lead market growth 93 6.3 AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE 94 6.3.1 IMAGE EVALUATION SOFTWARE 95 6.3.1.1 Enhanced clinical precision with ultrasound AI image analysis 95 6.3.2 RADIOLOGY SOFTWARE 96 6.3.2.1 Smart ultrasound diagnostics to boost growth 96 6.3.3 WORKFLOW PLANNING & SUPPORT SOFTWARE 97 6.3.3.1 Optimization of ultrasound workflow for better patient outcomes - key driver 97 6.3.4 OTHER AI SOLUTIONS 98 7 ULTRASOUND AI MARKET, BY BRAND 100 7.1 INTRODUCTION 101 7.2 ECHOPAC 101 7.2.1 IMPROVED PATIENT EXPERIENCE WITH ECHOPAC SOFTWARE IN HOSPITALS AND SURGICAL CENTERS 101 7.3 APLIO 102 7.3.1 IMAGE OPTIMIZATION AND REAL-TIME DECISION SUPPORT TO FUEL MARKET GROWTH 102 7.4 ACUSON 103 7.4.1 ADVANCED DIAGNOSTICS WITH AI-BASED ACUSON SYSTEM 103 7.5 BUTTERFLY 104 7.5.1 INTEGRATION OF AI IN SMARTPHONES & TABLETS TO DRIVE MARKET GROWTH 104 7.6 OTHER BRANDS 105 8 ULTRASOUND AI MARKET, BY APPLICATION 107 8.1 INTRODUCTION 108 8.2 OBSTETRICS/GYNECOLOGY 108 8.2.1 HIGH LEVEL OF INNOVATION TO DRIVE MARKET 108 8.3 RADIOLOGY/GENERAL IMAGING 110 8.3.1 TRANSFORMING DIAGNOSTIC WORKFLOWS WITH INTEGRATED AI MODEL 110 8.4 ORTHOPEDIC & MUSCULOSKELETAL 112 8.4.1 RISING PREVALENCE OF OSTEOARTHRITIS TO LEAD MARKET GROWTH 112 8.5 CARDIOLOGY 113 8.5.1 ACCELERATED CARDIAC ASSESSMENTS WITH AI BORDER MAPPING TO DRIVE SEGMENT 113 8.6 UROLOGICAL 115 8.6.1 WIDE USE IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO BOOST MARKET 115 8.7 OTHER APPLICATIONS 116 9 ULTRASOUND AI MARKET, BY END USER 117 9.1 INTRODUCTION 118 9.2 HOSPITALS & SURGICAL CENTERS 118 9.2.1 HIGH ADOPTION OF AI-INTEGRATED ULTRASOUND TO BOOST MARKET 118 9.3 IMAGING & SPECIALTY CLINICS 119 9.3.1 EARLY DISEASE DETECTION AND PERSONALIZED TREATMENT LEAD TO MARKET GROWTH 119 9.4 AMBULATORY CARE CENTERS 120 9.4.1 SUPPORTIVE EARLY DETECTION & PREVENTIVE CARE TO PROPEL MARKET GROWTH 120 9.5 MATERNITY & FERTILITY CLINICS 121 9.5.1 AI INTEGRATION SYSTEMS LEAD TO PRECISE AND EFFICIENT TREATMENT 121 9.6 OTHER END USERS 122 10 ULTRASOUND AI MARKET, BY REGION 124 10.1 INTRODUCTION 125 10.2 NORTH AMERICA 126 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 126 10.2.2 US 131 10.2.2.1 Presence of advanced healthcare infrastructure to drive market 131 10.2.3 CANADA 133 10.2.3.1 Investments in healthcare AI to drive market 133 10.3 EUROPE 135 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 135 10.3.2 GERMANY 139 10.3.2.1 Favorable healthcare policies and regulatory landscape to drive market 139 10.3.3 UK 141 10.3.3.1 Funding by government bodies to drive market 141 10.3.4 FRANCE 142 10.3.4.1 Increasing demand for routine health check-ups, prenatal care, and diagnostic procedures to drive market 142 10.3.5 ITALY 144 10.3.5.1 Increased availability of reimbursement coverage to drive market 144 10.3.6 SPAIN 146 10.3.6.1 Growing adoption of point-of-care ultrasound AI to drive market 146 10.3.7 REST OF EUROPE 148 10.4 ASIA PACIFIC 150 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 151 10.4.2 CHINA 155 10.4.2.1 Emphasis on modernization and expansion of healthcare infrastructure to drive market 155 10.4.3 JAPAN 158 10.4.3.1 Rise in breast cancer diagnosis using ultrasound AI to boost market 158 10.4.4 INDIA 160 10.4.4.1 Investments and funding activities to drive market 160 10.4.5 AUSTRALIA 162 10.4.5.1 Increasing investments in healthcare infrastructure to drive market 162 10.4.6 SOUTH KOREA 164 10.4.6.1 Rising investments in AI & conference events to drive market 164 10.4.7 REST OF ASIA PACIFIC 166 10.5 LATIN AMERICA 168 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 169 10.5.2 BRAZIL 173 10.5.2.1 Growing adoption of healthcare insurance to drive market 173 10.5.3 MEXICO 175 10.5.3.1 Investment in ultrasound AI devices to drive market 175 10.5.4 REST OF LATIN AMERICA 177 10.6 MIDDLE EAST & AFRICA 178 10.6.1 MACROECONOMIC OUTLOOK 179 10.6.2 GCC COUNTRIES 183 10.6.2.1 Government initiatives aimed at digital health and telemedicine to drive market 183 10.6.3 REST OF MIDDLE EAST & AFRICA 184 11 COMPETITIVE LANDSCAPE 187 11.1 INTRODUCTION 187 11.2 KEY PLAYER STRATEGIES 187 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND AI MARKET 188 11.3 REVENUE ANALYSIS, 2021–2024 189 11.4 MARKET SHARE ANALYSIS, 2024 190 11.4.1 RANKING OF KEY MARKET PLAYERS 191 11.5 COMPANY EVALUATION MATRIX: ULTRASOUND AI MARKET, 2024 192 11.5.1 STARS 192 11.5.2 EMERGING LEADERS 192 11.5.3 PERVASIVE PLAYERS 192 11.5.4 PARTICIPANTS 192 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 194 11.5.5.1 Company footprint 194 11.5.5.2 Region footprint 195 11.5.5.3 Product footprint 196 11.5.5.4 Application footprint 197 11.5.5.5 End user footprint 198 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024) 199 11.6.1 PROGRESSIVE COMPANIES 199 11.6.2 RESPONSIVE COMPANIES 199 11.6.3 DYNAMIC COMPANIES 199 11.6.4 STARTING BLOCKS 199 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 201 11.6.5.1 Detailed list of key startups/SMEs 201 11.6.5.2 Competitive benchmarking of key startups/SMEs 202 11.7 COMPANY VALUATION & FINANCIAL METRICS 204 11.7.1 FINANCIAL METRICS 204 11.7.2 COMPANY VALUATION 204 11.8 BRAND/PRODUCT COMPARISON 205 11.9 COMPETITIVE SCENARIO 206 11.9.1 PRODUCT LAUNCHES 206 11.9.2 DEALS 207 12 COMPANY PROFILES 208 12.1 KEY PLAYERS 208 12.1.1 GE HEALTHCARE 208 12.1.1.1 Business overview 208 12.1.1.2 Products offered 209 12.1.1.3 Recent developments 210 12.1.1.3.1 Product launches & approvals 210 12.1.1.3.2 Deals 212 12.1.1.3.3 Other developments 212 12.1.1.4 MnM view 213 12.1.1.4.1 Right to win 213 12.1.1.4.2 Strategic choices 213 12.1.1.4.3 Weaknesses & competitive threats 213 12.1.2 PHILIPS HEALTHCARE 214 12.1.2.1 Business overview 214 12.1.2.2 Products offered 215 12.1.2.3 Recent developments 217 12.1.2.3.1 Product launches & approvals 217 12.1.2.3.2 Deals 218 12.1.2.4 MnM view 218 12.1.2.4.1 Right to win 218 12.1.2.4.2 Strategic choices 218 12.1.2.4.3 Weaknesses & competitive threats 218 12.1.3 CANON MEDICAL SYSTEMS CORPORATION 219 12.1.3.1 Business overview 219 12.1.3.2 Products offered 220 12.1.3.3 Recent developments 221 12.1.3.3.1 Product launches 221 12.1.3.3.2 Deals 221 12.1.3.3.3 Expansions 222 12.1.3.4 MnM view 222 12.1.3.4.1 Right to win 222 12.1.3.4.2 Strategic choices 223 12.1.3.4.3 Weaknesses & competitive threats 223 12.1.4 SIEMENS HEALTHINEERS AG 224 12.1.4.1 Business overview 224 12.1.4.2 Products offered 225 12.1.4.3 Recent developments 226 12.1.4.3.1 Product launches 226 12.1.4.3.2 Deals 227 12.1.4.3.3 Expansions 227 12.1.4.4 MnM view 227 12.1.4.4.1 Right to win 227 12.1.4.4.2 Strategic choices 228 12.1.4.4.3 Weaknesses & competitive threats 228 12.1.5 FUJIFILM CORPORATION 229 12.1.5.1 Business overview 229 12.1.5.2 Products offered 230 12.1.5.3 Recent developments 231 12.1.5.3.1 Product launches 231 12.1.5.3.2 Deals 231 12.1.5.3.3 Expansions 232 12.1.5.4 MnM view 232 12.1.5.4.1 Right to win 232 12.1.5.4.2 Strategic choices 232 12.1.5.4.3 Weaknesses & competitive threats 232 12.1.6 HOLOGIC, INC. 233 12.1.6.1 Business overview 233 12.1.6.2 Products offered 234 12.1.6.2.1 Deals 235 12.1.6.2.2 Expansions 236 12.1.7 SAMSUNG ELECTRONICS CO., LTD. 237 12.1.7.1 Business overview 237 12.1.7.2 Products offered 238 12.1.7.3 Recent developments 239 12.1.7.3.1 Product launches 239 12.1.7.3.2 Deals 240 12.1.7.3.3 Other developments 240 12.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED 241 12.1.8.1 Business overview 241 12.1.8.2 Products offered 242 12.1.8.3 Recent developments 243 12.1.8.3.1 Product launches 243 12.1.8.3.2 Deals 244 12.1.8.3.3 Other developments 244   12.1.9 SONOSCAPE 245 12.1.9.1 Business overview 245 12.1.9.2 Products offered 245 12.1.10 KONICA MINOLTA, INC 246 12.1.10.1 Business overview 246 12.1.10.2 Products offered 247 12.1.10.3 Recent developments 248 12.1.10.3.1 Product launches & approvals 248 12.1.10.3.2 Deals 248 12.1.11 BUTTERFLY NETWORK 249 12.1.11.1 Business overview 249 12.1.11.2 Products offered 249 12.1.11.3 Recent developments 250 12.1.11.3.1 Product launches 250 12.1.11.3.2 Deals 250 12.1.11.3.3 Expansions 251 12.2 OTHER PLAYERS 252 12.2.1 EXO IMAGING 252 12.2.2 CHISON MEDICAL TECHNOLOGIES CO., LTD 253 12.2.3 ESASOTE 254 12.2.4 CLARIUS 255 12.2.5 EVIDENT VASCULAR 256 12.2.6 SMARTALPHA 257 12.2.7 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING 258 12.2.8 FRONTWAVE IMAGING 259 12.2.9 DELFT IMAGING 260 12.2.10 EDAN INSTRUMENTS, INC 261 12.2.11 ECHONOUS INC. 262 12.2.12 KOIOS MEDICAL 263 12.2.13 BIOTICS AI 264 12.2.14 TERASON 265 12.2.15 BK MEDICAL 266 12.2.16 MAUI IMAGING 267 12.2.17 SONOLOGIC 268 12.2.18 CONTEXTVISION 269 13 APPENDIX 270 13.1 DISCUSSION GUIDE 270 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 274 13.3 CUSTOMIZATION OPTIONS 276 13.4 RELATED REPORTS 276 13.5 AUTHOR DETAILS 277
圖表清單 List of Tables & Figures
TABLE 1 ULTRASOUND AI MARKET: INCLUSIONS & EXCLUSIONS 26 TABLE 2 KEY TECHNOLOGICAL ADVANCEMENTS IN POCUS 49 TABLE 3 ULTRASOUND AI MARKET: IMPACT OF PORTER’S FIVE FORCES 57 TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 60 TABLE 5 KEY BUYING CRITERIA, BY END USER 61 TABLE 6 ULTRASOUND AI MARKET: KEY PATENTS, 2022–2024 63 TABLE 7 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2024 (USD THOUSAND) 64 TABLE 8 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020-2024 (USD THOUSAND) 65 TABLE 9 ULTRASOUND AI MARKET: KEY CONFERENCES & EVENTS, 2025–2026 66 TABLE 10 ULTRASOUND AI MARKET: CURRENT UNMET NEEDS 67 TABLE 11 ULTRASOUND AI MARKET: ROLE OF COMPANIES IN ECOSYSTEM 68 TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 69 TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION 75 TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76 TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76 TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 77 TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 78 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 23 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022–2024 (USD THOUSAND) 86 TABLE 24 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, 2024 (USD) 86 TABLE 25 US: MAJOR CPT CODES FOR ULTRASOUND, 2025 87 TABLE 26 ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 89 TABLE 27 AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 90 TABLE 28 AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 90 TABLE 29 HANDHELD: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 91 TABLE 30 CART-BASED: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 92 TABLE 31 POINT OF CARE: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 94 TABLE 32 AI-ENABLED SOLUTIONS/SOFTWARE: ULTRASOUND AI MARKET, BY TYPE, 2023–2030 (USD MILLION) 94 TABLE 33 AI-ENABLED SOLUTIONS/SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 34 IMAGE EVALUATION SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 35 RADIOLOGY SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 36 WORKFLOW PLANNING & SUPPORT SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 98 TABLE 37 OTHER AI SOLUTIONS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 38 ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 101 TABLE 39 ECHOPAC: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 40 APLIO: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 41 ACUSON: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 42 BUTTERFLY: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 43 OTHER BRANDS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 44 ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 108 TABLE 45 OBSTETRICS/GYNECOLOGY: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 46 COMPARISON OF HUMAN RADIOLOGISTS VS. AI MODELS 111 TABLE 47 RADIOLOGY/GENERAL IMAGING: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 48 ORTHOPEDIC & MUSCULOSKELETAL: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 49 CARDIOLOGY: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 50 UROLOGICAL: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 51 OTHER APPLICATIONS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 52 ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 118 TABLE 53 HOSPITALS & SURGICAL CENTERS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 54 IMAGING & SPECIALTY CLINICS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 55 AMBULATORY CARE CENTERS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 56 MATERNITY & FERTILITY CLINICS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 57 OTHER END USERS: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 58 ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 59 NUMBER OF UNITS SOLD BY BUTTERFLY NETWORK 125 TABLE 60 NORTH AMERICA: MACROECONOMIC OUTLOOK 126 TABLE 61 NORTH AMERICA: ULTRASOUND AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 62 NORTH AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 128 TABLE 63 NORTH AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 128 TABLE 64 NORTH AMERICA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 129 TABLE 65 NORTH AMERICA: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 129 TABLE 66 NORTH AMERICA: ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 130 TABLE 67 NORTH AMERICA: ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 130 TABLE 68 US: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 132 TABLE 69 US: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 132 TABLE 70 US: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 71 CANADA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 134 TABLE 72 CANADA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 134 TABLE 73 CANADA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 134 TABLE 74 EUROPE: MACROECONOMIC OUTLOOK 135 TABLE 75 EUROPE: ULTRASOUND AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 76 EUROPE: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 136 TABLE 77 EUROPE: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 137 TABLE 78 EUROPE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 79 EUROPE: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 138 TABLE 80 EUROPE: ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138 TABLE 81 EUROPE: ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 139 TABLE 82 GERMANY: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 140 TABLE 83 GERMANY: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 140 TABLE 84 GERMANY: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 140 TABLE 85 UK: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 141 TABLE 86 UK: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 142 TABLE 87 UK: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 88 FRANCE: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 143 TABLE 89 FRANCE : AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 144 TABLE 90 FRANCE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 91 ITALY: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 145 TABLE 92 ITALY: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 145 TABLE 93 ITALY: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 94 SPAIN: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 147 TABLE 95 SPAIN: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 147 TABLE 96 SPAIN: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 148 TABLE 97 REST OF EUROPE: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 149 TABLE 98 REST OF EUROPE: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 149 TABLE 99 REST OF EUROPE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 100 ASIA PACIFIC: ULTRASOUND AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 101 ASIA PACIFIC: MACROECONOMIC OUTLOOK 151 TABLE 102 ASIA PACIFIC: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 152 TABLE 103 ASIA PACIFIC: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 153 TABLE 104 ASIA PACIFIC: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 105 ASIA PACIFIC: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 154 TABLE 106 ASIA PACIFIC: ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 154 TABLE 107 ASIA PACIFIC: ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 108 CHINA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 157 TABLE 109 CHINA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 157 TABLE 110 CHINA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 111 JAPAN: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 159 TABLE 112 JAPAN: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 159 TABLE 113 JAPAN: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 114 INDIA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 161 TABLE 115 INDIA: AI-ENABLED ULTRASOUND SYSTEMS, MARKET, BY TYPE, 2023–2030 MILLION) 161 TABLE 116 INDIA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 117 AUSTRALIA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 163 TABLE 118 AUSTRALIA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 163 TABLE 119 AUSTRALIA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 120 SOUTH KOREA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 165 TABLE 121 SOUTH KOREA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 165 TABLE 122 SOUTH KOREA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 123 REST OF ASIA PACIFIC: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 167 TABLE 124 REST OF ASIA PACIFIC: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 168 TABLE 125 REST OF ASIA PACIFIC: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 126 LATIN AMERICA: MACROECONOMIC OUTLOOK 169 TABLE 127 LATIN AMERICA: ULTRASOUND AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 128 LATIN AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 170 TABLE 129 LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 171 TABLE 130 LATIN AMERICA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 131 LATIN AMERICA: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 172 TABLE 132 LATIN AMERICA: ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 133 LATIN AMERICA: ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 134 BRAZIL: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 174 TABLE 135 BRAZIL: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 174 TABLE 136 BRAZIL: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 137 MEXICO: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 176 TABLE 138 MEXICO: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 176 TABLE 139 MEXICO: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 140 REST OF LATIN AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 177 TABLE 141 REST OF LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 177 TABLE 142 REST OF LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 143 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 179 TABLE 144 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 145 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 180 TABLE 146 MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 180 TABLE 147 MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 148 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 181 TABLE 149 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182 TABLE 150 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 151 GCC COUNTRIES: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 183 TABLE 152 GCC COUNTRIES: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 184 TABLE 153 GCC COUNTRIES: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 154 REST OF MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 185 TABLE 155 REST OF MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 185 TABLE 156 REST OF MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 157 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN ULTRASOUND AI MARKET 188 TABLE 158 ULTRASOUND AI MARKET: DEGREE OF COMPETITION 190 TABLE 159 ULTRASOUND MARKET: REGION FOOTPRINT 195 TABLE 160 ULTRASOUND AI MARKET: PRODUCT FOOTPRINT 196 TABLE 161 ULTRASOUND AI MARKET: APPLICATION FOOTPRINT 197 TABLE 162 ULTRASOUND AI MARKET: END USER FOOTPRINT 198 TABLE 163 ULTRASOUND AI MARKET: DETAILED LIST OF KEY STARTUPS/SMES 201 TABLE 164 ULTRASOUND AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 202 TABLE 165 ULTRASOUND AI MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2025 206 TABLE 166 ULTRASOUND AI MARKET: DEALS, JANUARY 2021–AUGUST 2025 207 TABLE 167 GE HEALTHCARE: COMPANY OVERVIEW 208 TABLE 168 GE HEALTHCARE: PRODUCTS OFFERED 209 TABLE 169 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 210 TABLE 170 GE HEALTHCARE: DEALS, JANUARY 2021– AUGUST 2025 212 TABLE 171 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021– AUGUST 2025 212 TABLE 172 PHILIPS HEALTHCARE: COMPANY OVERVIEW 214 TABLE 173 PHILIPS HEALTHCARE: PRODUCTS OFFERED 215 TABLE 174 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021– AUGUST 2025 217 TABLE 175 PHILIPS HEALTHCARE: DEALS, JANUARY 2021– AUGUST 2025 218 TABLE 176 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 219 TABLE 177 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 220 TABLE 178 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 221 TABLE 179 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021– AUGUST 2025 221 TABLE 180 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS, JANUARY 2021– AUGUST 2025 222 TABLE 181 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 224 TABLE 182 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 225 TABLE 183 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 226 TABLE 184 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021– AUGUST 2025 227 TABLE 185 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021– AUGUST 2025 227 TABLE 186 FUJIFILM CORPORATION: COMPANY OVERVIEW 229 TABLE 187 FUJIFILM CORPORATION: PRODUCTS OFFERED 230 TABLE 188 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 231 TABLE 189 FUJIFILM CORPORATION: DEALS, JANUARY 2021– AUGUST 2025 231 TABLE 190 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2021– AUGUST 2025 232 TABLE 191 HOLOGIC, INC.: COMPANY OVERVIEW 233 TABLE 192 HOLOGIC, INC.: PRODUCTS OFFERED 234 TABLE 193 HOLOGIC, INC.: DEALS, JANUARY 2021– AUGUST 2025 235 TABLE 194 HOLOGIC, INC.: EXPANSIONS, JANUARY 2021– AUGUST 2025 236 TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW 237 TABLE 196 SAMSUNG ELECTRONICS CO., LTD.: PRODUCTS OFFERED 238 TABLE 197 SAMSUNG ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 239 TABLE 198 SAMSUNG ELECTRONICS CO., LTD.: DEALS, JANUARY 2021– AUGUST 2025 240 TABLE 199 SAMSUNG ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025 240 TABLE 200 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY OVERVIEW 241 TABLE 201 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCTS OFFERED 242 TABLE 202 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 243 TABLE 203 MINDRAY MEDICAL INTERNATIONAL LIMITED: DEALS, JANUARY 2021– AUGUST 2025 244 TABLE 204 MINDRAY MEDICAL INTERNATIONAL LIMITED: OTHER DEVELOPMENTS, JANUARY 2021– AUGUST 2025 244 TABLE 205 SONOSCAPE: COMPANY OVERVIEW 245 TABLE 206 SONOSCAPE: PRODUCTS OFFERED 245 TABLE 207 KONICA MINOLTA, INC.: COMPANY OVERVIEW 246 TABLE 208 KONICA MINOLTA, INC: PRODUCTS OFFERED 247 TABLE 209 KONICA MINOLTA, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021– AUGUST 2025 248 TABLE 210 KONICA MINOLTA, INC: DEALS, JANUARY 2021– AUGUST 2025 248 TABLE 211 BUTTERFLY NETWORK: COMPANY OVERVIEW 249 TABLE 212 BUTTERFLY NETWORK: PRODUCTS OFFERED 249 TABLE 213 BUTTERFLY NETWORK: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 250 TABLE 214 BUTTERFLY NETWORK: DEALS, JANUARY 2021– AUGUST 2025 250 TABLE 215 BUTTERFLY NETWORK: EXPANSIONS, JANUARY 2021– AUGUST 2025 251 TABLE 216 EXO IMAGING: COMPANY OVERVIEW 252 TABLE 217 CHISON MEDICAL TECHNOLOGIES CO., LTD: COMPANY OVERVIEW 253 TABLE 218 ESASOTE: COMPANY OVERVIEW 254 TABLE 219 CLARIUS: COMPANY OVERVIEW 255 TABLE 220 EVIDENT VASCULAR: COMPANY OVERVIEW 256 TABLE 221 SMARTALPHA: COMPANY OVERVIEW 257 TABLE 222 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING: COMPANY OVERVIEW 258 TABLE 223 FRONTWAVE IMAGING: COMPANY OVERVIEW 259 TABLE 224 DELFT IMAGING: COMPANY OVERVIEW 260 TABLE 225 EDAN INSTRUMENTS, INC: COMPANY OVERVIEW 261 TABLE 226 ECHONOUS INC.: COMPANY OVERVIEW 262 TABLE 227 KOIOS MEDICAL: COMPANY OVERVIEW 263 TABLE 228 BIOTICS AI: COMPANY OVERVIEW 264 TABLE 229 TERASON: COMPANY OVERVIEW 265 TABLE 230 BK MEDICAL: COMPANY OVERVIEW 266 TABLE 231 MAUI IMAGING: COMPANY OVERVIEW 267 TABLE 232 SONOLOGIC: COMPANY OVERVIEW 268 TABLE 233 CONTEXTVISION: COMPANY OVERVIEW 269 FIGURE 1 RESEARCH DESIGN 28 FIGURE 2 KEY SECONDARY SOURCES 29 FIGURE 3 PRIMARY SOURCES 31 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 32 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33 FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 34 FIGURE 7 ULTRASOUND AI MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 35 FIGURE 8 ULTRASOUND AI MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 36 FIGURE 9 TOP-DOWN APPROACH 37 FIGURE 10 GLOBAL MARKET GROWTH PROJECTIONS 38 FIGURE 11 DATA TRIANGULATION METHODOLOGY 39 FIGURE 12 ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 42 FIGURE 13 ULTRASOUND AI MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 43 FIGURE 14 ULTRASOUND AI MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 43 FIGURE 15 INTEGRATION WITH OTHER IMAGING MODALITIES TO DRIVE MARKET 45 FIGURE 16 HOSPITALS & SURGICAL CENTERS TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025 46 FIGURE 17 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 47 FIGURE 18 ULTRASOUND AI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48 FIGURE 19 ULTRASOUND AI MARKET: VALUE CHAIN ANALYSIS 55 FIGURE 20 ULTRASOUND AI MARKET: SUPPLY CHAIN ANALYSIS 57 FIGURE 21 ULTRASOUND AI MARKET: PORTER’S FIVE FORCES 58 FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 59 FIGURE 23 KEY BUYING CRITERIA, BY END USER 60 FIGURE 24 PATENT ANALYSIS FOR ULTRASOUND AI MARKET (JANUARY 2014–AUGUST 62 FIGURE 25 ULTRASOUND AI MARKET: ECOSYSTEM ANALYSIS 67 FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72 FIGURE 27 INVESTMENT & FUNDING SCENARIO, 2019–2023 82 FIGURE 28 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 83 FIGURE 29 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 83 FIGURE 30 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022–2024 (USD) 85 FIGURE 31 NORTH AMERICA: ULTRASOUND AI MARKET SNAPSHOT 127 FIGURE 32 ASIA PACIFIC: ULTRASOUND AI MARKET SNAPSHOT 152 FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN ULTRASOUND AI MARKET, 2021–2024 (USD BILLION) 189 FIGURE 34 ULTRASOUND AI MARKET SHARE ANALYSIS (2024) 190 FIGURE 35 RANKING OF KEY PLAYERS IN ULTRASOUND AI MARKET, 2024 191 FIGURE 36 ULTRASOUND AI MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 193 FIGURE 37 ULTRASOUND AI MARKET: COMPANY FOOTPRINT 194 FIGURE 38 ULTRASOUND AI MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 200 FIGURE 39 EV/EBITDA OF KEY VENDORS 204 FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 204 FIGURE 41 ULTRASOUND AI MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 205 FIGURE 42 GE HEALTHCARE: COMPANY SNAPSHOT 209 FIGURE 43 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 215 FIGURE 44 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 220 FIGURE 45 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 225 FIGURE 46 FUJIFILM CORPORATION: COMPANY SNAPSHOT 230 FIGURE 47 HOLOGIC, INC.: COMPANY SNAPSHOT 234 FIGURE 48 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 238 FIGURE 49 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT 241 FIGURE 50 KONICA MINOLTA, INC: COMPANY SNAPSHOT 247

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們